SCHOTT Pharma

SCHOTT Pharma is a provider of drug containment and delivery solutions for injectables, ranging from prefillable syringes, to cartridges, vials, and ampoules. It manufactures syriQ BioPure® glass prefillable syringes for biologics, and SCHOTT TOPPAC prefillable syringes, made of COP.

Headquarters
SCHOTT Pharma AG & Co KGaA
Hattenbergstrasse 10
55122 Mainz
Germany

Phone / Contact

T: +49 6131 66-0
E: [email protected]

Connect

SCHOTT Pharma designs drug containment and delivery solutions grounded in science to ensure that medications are safe and easy to use. The company’s portfolio ranges from prefillable glass and polymer syringes to cartridges, vials and ampoules. SCHOTT employs a team of around 4,700 people from over 60 countries and is represented in all main pharmaceutical hubs with 16 manufacturing sites in Europe, North and South America and Asia. SCHOTT holds over 1,000 patents and technologies and develops innovative technologies in a state-of-the-art R&D centre in Switzerland.

SCHOTT Pharma AG & Co KGaA is headquartered in Mainz, Germany and listed on the Frankfurt Stock Exchange as part of the MDAX. The company is part of SCHOTT AG, which is owned by the Carl Zeiss Foundation. SCHOTT Pharma is committed to sustainable development with the strategic goal of becoming climate-neutral by 2030. Currently, SCHOTT Pharma has over 1,800 customers, including the top 30 leading pharma manufacturers for injectable drugs and generated revenue of €957 million (£793 million) in the 2024 fiscal year.

Articles by SCHOTT Pharma

PREFILLED SYRINGES

Isabelle Jeangoudoux

LAUNCHING A LARGE-VOLUME PREFILLABLE GLASS SYRINGE SYSTEM: RELIABLE SUBCUTANEOUS DRUG DELIVERY

Isabelle Jeangoudoux and Sven Pohle introduce SCHOTT Pharma’s new syriQ BioPure 5.5 mL staked-needle prefillable glass syringe and explain how this solution meets the growing need for large-volume subcutaneous drug delivery.

Philipp Ludihuser

PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY

Philipp Ludihuser and Arne Kloke highlight how SCHOTT Pharma’s collaboration with customers and partners in the pharmaceutical industry reduces the carbon emissions from the production of vials, cartridges, ampoules and syringes, as well as introducing circular solutions to increase resource efficiency.

Dr Uwe Rothhaar

PACKAGING MATERIAL IDENTIFICATION TO ENSURE SELECTION OF BEST-MATCHING COMPONENTS FOR PARENTERAL DRUGS

Uwe Rothhaar, Daniel Haines, Matthias Bicker and Thomas Schmidt discuss the analytical techniques used to identify the material components and composition of primary containers for injectable drug products.

PREFILLED SYRINGES

Tom Van Ginneken

DELIVERY SOLUTIONS FOR DEEP-COLD DRUGS

Tom Van Ginneken considers how the growing pipeline of molecules that require cold storage has highlighted the need for better drug containment and delivery methods and highlights the potential SCHOTT TOPPAC^® freeze syringes offer as a potential solution.

PREFILLED SYRINGES

Michelle Deutsch

TAKING INTEGRATED NEEDLE SAFETY SYSTEMS FOR PREFILLED SYRINGES TO THE NEXT LEVEL

Michelle Deutsch and John Merhige discuss the needle safety requirements of prefilled syringes and consider how SCHOTT TOPPAC^® and syriQ^® PFS with Credence Companion^® technology combine to meet these challenges, while ensuring the device meets sustainability demands.

Dr Matthias Bicker

COMPARATIVE EXTRACTABLE STUDIES FOR INJECTABLES AND MEDICAL DEVICES ALIGNED WITH USP <1663> AND ISO 10993 GUIDELINES

Matthias Bicker, Michael Müller, Marc Mittermüller, Daniel Haines and Uwe Rothhaar discuss the regulatory requirements that need to be considered when designing an extractables and leachables study for a drug product or medical device. To illustrate the subject further, the authors provide two example studies, each following a different set of regulatory guidelines.

INDUSTRIALISATION

THE FUTURE OF SMART FILL-AND-FINISH

Diana Löber discusses new developments in digitised pharmaceutical manufacturing and the role SCHOTT’s Smart Containers can play in traceability along the entire value chain.

PREFILLED SYRINGES

Christian Helbig

FINDING THE RIGHT PACKAGING FOR BIOLOGIC DRUGS

Christian Helbig introduces a new 2.25 mL version of SCHOTT’s syriQ BioPure^® prefillable syringes designed specifically for the biologics market and, developed in partnership with WL Gore, the world’s first silicone-free glass syringe system.

Dominique Bauert

PRIMARY PACKAGING FOR WEARABLE INJECTION DEVICES

Dominique Bauert and Anil Kumar Busimi provide an overview of existing wearable injector solutions and new requirements, with a focus on the role of the primary packaging inside the devices.

PREFILLED SYRINGES

Florence Buscke

INNOVATIVE SOLUTIONS FOR PACKAGING BIOLOGICS

Florence Buscke, Nicolas Eon and Tom Van Ginneken outline SCHOTT’s offering across both glass and polymer primary containers for pharmaceuticals, emphasising their advantages in the rapidly growing biologics market.

Tom Van Ginneken

TOM VAN GINNEKEN, SCHOTT

Tom Van Ginneken discusses the advantages of polymers as a material for primary pharmaceutical packaging and how the company supports pharma manufacturers with engineering capabilities for individualised containers and rapid prototyping.

PREFILLED SYRINGES

Fabian Stöcker

CREATING PREFILLABLE SYRINGES FOR THE BIOLOGICS MARKET

Nicolas Eon and Fabian Stöcker discuss syriQ BioPure^®, a high-end prefillable syringe for biologics, which integrates seamlessly with autoinjectors and an innovative filling platform.

ADAPTIQ^® & VIALS DC

SCHOTT has expanded its adaptiQ^® portfolio of ready-to-use pharma containers to meet growing market demand from drug manufacturers and, separately, a new series of studies has once again demonstrated the effectiveness of SCHOTT Vials Delamination Controlled (Vials DC).

PREFILLED SYRINGES

Dr Folker Steden

PRODUCT SHOWCASE: SCHOTT’s SYRIQ^® AND TOPPAC^® RIGID CAPS

Schott has added new closure systems to its already extensive portfolio of prefillable syringes. Offering more flexibility for pharma companies while keeping patients safe.

Dr Folker Steden

PRODUCT SHOWCASE: PERFEXION™

perfeXion™ is a new quality approach from Schottt, which controls every inch of pharma glass tubing and with its launch the company pushes towards a zero-defect philosophy in pharmaceutical glass tubing production.

PREFILLED SYRINGES

Anil Kumar Busimi

OPTIMISATION OF SYRINGE PERFORMANCE FOR OCULAR INJECTIONS & BEYOND: IMPACT OF SILICONE OIL

Susan M Dounce and Anil Kumar Busimi describe the increasingly significant role of prefilled syringes in the delivery of ocular therapeutics.

Top